FDA NDC Directory · JSON-LD · Markdown

TEPEZZA

NDC 75987-130 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameteprotumumab
Labeler / ManufacturerHorizon Therapeutics USA, Inc.
Marketing categoryBiologic License Application · App BLA761143
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsTEPROTUMUMAB (500 mg/1)
Marketing started20200121
Package count1

External sources

Source: openFDA. Public-domain (CC0).